Tanshinone IIA as a Cardioprotective Agent: Molecular Mechanisms, Pharmacological Effects, Pharmacokinetics, and Clinical Perspectives
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-26
DOI: 10.2147/dddt.s637161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von QingQuan Pan und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pan, Q., Ji, K., Zhao, D., Yang, C., & Li, J. (2026). Tanshinone IIA as a Cardioprotective Agent: Molecular Mechanisms, Pharmacological Effects, Pharmacokinetics, and Clinical Perspectives. Drug Design, Development and Therapy, Volume 20, 1-26. https://doi.org/10.2147/dddt.s637161
Vancouver
Pan Q, Ji K, Zhao D, Yang C, Li J. Tanshinone IIA as a Cardioprotective Agent: Molecular Mechanisms, Pharmacological Effects, Pharmacokinetics, and Clinical Perspectives. Drug Design, Development and Therapy. 2026;Volume 20:1-26. doi:10.2147/dddt.s637161
BibTeX
@article{Pan2026,
author = {Pan, QingQuan and Ji, Kui and Zhao, DaHua and Yang, ChunKun and Li, Jun},
title = {Tanshinone IIA as a Cardioprotective Agent: Molecular Mechanisms, Pharmacological Effects, Pharmacokinetics, and Clinical Perspectives},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--26},
doi = {10.2147/dddt.s637161}
}
EUVIMED